| # | % | |||||
|---|---|---|---|---|---|---|
| 751 | ALEXION PHARMACEUTIC | 106,667 | 14,850,000 | 1.03% | ||
| 752 | MONDELEZ INTL INC | 382,522 | 15,347,000 | 1.06% | ||
| 753 | BAIDU INC | 86,931 | 16,593,000 | 1.15% | ||
| 754 | GILEAD SCIENCES INC | 191,930 | 17,631,000 | 1.22% | ||
| 755 | ABBVIE INC | 312,483 | 17,849,000 | 1.23% | ||
| 756 | TEVA PHARMACEUTICAL INDS LTD | 335,709 | 17,964,000 | 1.24% | ||
| 757 | ALTRIA GROUP INC | 292,287 | 18,315,000 | 1.27% | ||
| 758 | ALERE INC | 384,325 | 19,451,000 | 1.35% | ||
| 759 | CELGENE CORP | 215,902 | 21,610,000 | 1.50% | ||
| 760 | CAMERON INTERNATIONAL COMPANY | 343,003 | 22,998,000 | 1.59% | ||
| 761 | PHILIP MORRIS INTL INC | 244,268 | 23,965,000 | 1.66% | ||
| 762 | WORLD FUEL SVCS CORP | 541,335 | 26,298,000 | 1.82% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001563592-16-000009, filed 2016.05.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
